Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Bioeconomy Capital

Bioeconomy Capital

Bioeconomy Capital is a biotechnology investment firm. The primary focus of Bioeconomy Captial is the industrialization of early stage biotechnology companies operating within the bioeconomy making products such as materials, chemicals, and enzymes.

Bioeconomy Capital is a biotechnology investment firm. The primary focus of Bioeconomy Captial is the industrialization of early stage biotechnology companies operating within the bioeconomy making products such as materials, chemicals, and enzymes.

Completion of Bioeconomy Fund 1

On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.

Investments

Bioeconomy Capital is interested in accelerating the strategic analysis of building blueprints and releasing technological capabilities. They look to support synthetic biology and related fields through investments. The company looks to segregate their investments into subsectors including, biologics, crops, and industrial products.

Timeline

January 1, 2017
Completion of Bioeconomy Fund 1

On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.

Invested in

Patents

Further Resources

Title
Author
Link
Type
Date

GBS 2018: Bioeconomy leaders foster shift to sustainable industry production

BIOCOM AG

News article

Xconomy: Seattle Area Had a Middling 2017 for Venture Investment, Fundraising

Benjamin Romano

News article

References

Golden logo
By using this site, you agree to our Terms & Conditions.